<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>aortic aneurysm &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/aortic-aneurysm/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Sun, 20 Sep 2026 23:14:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.1</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>aortic aneurysm &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Calcium Channel TRPV4 Emerges as a Key Player in Marfan Syndrome Aortic Disease</title>
		<link>https://scienmag.com/calcium-channel-trpv4-emerges-as-a-key-player-in-marfan-syndrome-aortic-disease/</link>
		
		<dc:creator><![CDATA[Juliet Wilcox]]></dc:creator>
		<pubDate>Sun, 20 Sep 2026 23:14:00 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[aortic aneurysm]]></category>
		<category><![CDATA[aortic aneurysm risk]]></category>
		<category><![CDATA[aortic wall weakening mechanisms]]></category>
		<category><![CDATA[aortopathy]]></category>
		<category><![CDATA[Biochemical Genetics]]></category>
		<category><![CDATA[calcium channel]]></category>
		<category><![CDATA[calcium signaling in vascular health]]></category>
		<category><![CDATA[connective tissue disorders]]></category>
		<category><![CDATA[extracellular matrix remodeling]]></category>
		<category><![CDATA[fibrillin-1 gene mutation]]></category>
		<category><![CDATA[gene expression]]></category>
		<category><![CDATA[genetic factors in aortic rupture]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[Marfan syndrome]]></category>
		<category><![CDATA[mechanosensitive genes in cardiovascular disease]]></category>
		<category><![CDATA[mechanotransduction]]></category>
		<category><![CDATA[mechanotransduction in Marfan syndrome]]></category>
		<category><![CDATA[NF-κB pathway]]></category>
		<category><![CDATA[novel targets for Marfan syndrome treatment]]></category>
		<category><![CDATA[TRPV4]]></category>
		<category><![CDATA[TRPV4 calcium channel role]]></category>
		<category><![CDATA[vascular smooth muscle cell response]]></category>
		<category><![CDATA[vascular smooth muscle cells]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=203768</guid>

					<description><![CDATA[A new study identifies the mechanosensitive calcium channel TRPV4 as a top candidate driving the inflammatory and remodeling behavior of aortic smooth muscle cells in Marfan syndrome.]]></description>
										<content:encoded><![CDATA[<p>Marfan syndrome has long been understood as a disease of connective tissue, driven by mutations in the gene that encodes fibrillin-1, a structural protein that gives the body&#8217;s elastic fibers their resilience. Yet the most feared consequence of the condition is not skeletal or ocular, but cardiovascular: the progressive weakening of the aorta, the body&#8217;s largest artery, which can dilate, tear, and rupture with little warning. For decades, researchers have focused on the structural failure of the arterial wall. A new study published in Biochemical Genetics shifts attention to a different question—how the cells inside that wall sense and respond to the mechanical forces that the failing matrix can no longer properly transmit. The answer, the researchers report, may lie in a single calcium channel called TRPV4.</p>
<p>The research team, led by Jian Liu, Jin Bai, Cheng Deng, and Zukai Wu of the Third People&#8217;s Hospital of Xinjiang Uygur Autonomous Region and Union Hospital of Huazhong University of Science and Technology, set out to identify the mechanosensitive genes that behave abnormally in the vascular smooth muscle cells of patients with Marfan syndrome. These cells form the muscular middle layer of the aortic wall, and their behavior is exquisitely sensitive to the mechanical environment. When the extracellular matrix deteriorates, as it does in Marfan syndrome, the mechanical cues reaching these cells are distorted, and the cells respond with a maladaptive program of remodeling, proliferation, and inflammation that further weakens the vessel.</p>
<p>To find the molecular switches behind this response, the team re-analyzed publicly available transcriptomic data from the dataset GSE128101, comparing gene expression in aortic vascular smooth muscle cells derived from Marfan syndrome patients with those from healthy donors. The screen identified 436 differentially expressed genes. Functional enrichment analysis revealed that these genes clustered around several interconnected themes: extracellular matrix remodeling, mechanotransduction—the process by which cells convert mechanical stimuli into biochemical signals—inflammatory signaling, and cytoskeletal organization. In other words, the genetic signature of Marfan aortopathy is not simply a story of structural collapse, but of cells actively misreading their mechanical world.</p>
<p>Narrowing the field from hundreds of candidate genes to the most plausible mechanosensitive regulators required a layered computational strategy. The researchers applied protein-protein interaction analysis to map how the differentially expressed genes connect functionally, used pathway enrichment to highlight biological themes, and then employed a statistical feature-selection method known as minimum redundancy maximum relevance, which favors genes that are strongly associated with the disease while avoiding overlap with one another. The top-ranked candidate to emerge from this pipeline was TRPV4, a calcium-permeable ion channel well known in the mechanobiology literature for its role in translating stretch, pressure, and matrix stiffness into intracellular calcium signals. A second channel, TRPM5, was also identified as an overlapping candidate.</p>
<p>The team then moved from computation to the laboratory. Using quantitative reverse-transcription polymerase chain reaction on primary aortic medial smooth muscle cells isolated from Marfan syndrome patients and from organ donors, they confirmed that both TRPV4 and TRPM5 are expressed at significantly higher levels in the patient-derived cells. Immunofluorescence imaging added a further layer of evidence: in the Marfan-derived cells, TRPV4 showed enhanced localization at the cell membrane, the position from which the channel is best placed to sense mechanical forces and admit calcium. The patient cells also displayed elevated expression of inflammatory genes, suggesting that the channel&#8217;s overabundance coincides with an activated inflammatory state.</p>
<p>To test whether TRPV4 is merely a bystander or an active driver of this dysfunctional behavior, the researchers manipulated the channel&#8217;s expression in primary human aortic smooth muscle cells. When they overexpressed TRPV4, the cells became more proliferative, closed scratch wounds more rapidly in migration assays, and secreted higher levels of inflammatory cytokines. Critically, the overexpression also increased phosphorylation of components of the NF-κB pathway, a canonical inflammatory signaling cascade whose activation in the vessel wall is a recognized hallmark of aneurysm progression. When the researchers silenced TRPV4 using small interfering RNA, the opposite pattern emerged: proliferation slowed, wound closure diminished, cytokine secretion fell, and NF-κB phosphorylation decreased.</p>
<p>These results position TRPV4 as a leading mechanosensitive candidate associated with the vascular smooth muscle cell remodeling and inflammatory activation that characterize Marfan aortopathy. The finding fits within a broader and rapidly growing body of evidence implicating mechanosensitive ion channels in vascular disease. Recent studies have shown that deletion of endothelial TRPV4 protects the heart from pressure overload-induced hypertrophy, that deficiency of endothelial TRPV4 channels ameliorates experimental abdominal aortic aneurysm, and that the TRPV4-YAP axis mediates cytoskeletal and extracellular matrix remodeling in other tissues. TRPV4 has also been linked to vascular calcification and aortic stiffening, suggesting that the channel sits at a convergence point for multiple forms of arterial pathology.</p>
<p>The mechanistic logic of the new findings is compelling. In a healthy aorta, fibrillin-1-rich elastic fibers transmit mechanical load smoothly to smooth muscle cells, which maintain a quiescent, contractile phenotype. In Marfan syndrome, the fragmented matrix alters the pattern of force transmission, and the study suggests that TRPV4, abundant and membrane-enriched in the patient cells, converts this distorted mechanical input into pathological calcium entry. Calcium influx through TRPV4 would then activate downstream signaling, including NF-κB, driving the cells toward a synthetic, proliferative, and inflammatory state. This phenotypic switching of smooth muscle cells is widely regarded as a central event in aneurysm formation, and a channel that couples mechanical dysfunction to inflammatory activation is an attractive node for intervention.</p>
<p>The authors are careful to frame their conclusions as exploratory. The study relied on re-analysis of a public dataset with a limited number of samples, and although the qRT-PCR validation in primary patient cells strengthens the case, larger cohorts will be needed to confirm the consistency of the TRPV4 signature across the genetically and clinically heterogeneous Marfan population. The functional experiments were conducted in primary human aortic smooth muscle cells in vitro, which capture important aspects of the disease but cannot fully reproduce the complex mechanical and humoral environment of a living aneurysmal aorta. Direct mechanistic assays—for example, calcium imaging under controlled mechanical stimulation, or pharmacological blockade of TRPV4 in Marfan animal models—will be required to establish causality and to determine whether the channel is a viable biomarker or therapeutic target.</p>
<p>Even with those caveats, the study adds a significant piece to the mechanobiological puzzle of Marfan syndrome. Current clinical management of the Marfan aorta relies heavily on imaging surveillance, blood pressure control, and, in many cases, prophylactic surgical repair. Drugs such as beta-blockers and angiotensin receptor blockers slow but do not halt aortic dilation, and the search for molecular targets that address the underlying cellular dysfunction remains intense. If TRPV4&#8217;s role is confirmed in larger studies and disease models, the channel could offer a way to intervene at the point where mechanical failure is translated into cellular pathology—potentially allowing clinicians to quiet the inflammatory, remodeling program before the aorta reaches a dangerous diameter. In a condition where the difference between stability and catastrophe is measured in millimeters, a molecular handle on that translation would be a welcome advance.</p>
<p><strong>Subject of Research:</strong> Mechanosensitive gene programs, particularly the TRPV4 calcium channel, in Marfan syndrome aortopathy</p>
<p><strong>Article Title:</strong> TRPV4 is Associated with a Marfan Syndrome-Related Mechanosensitive Gene Program in Aortic Smooth Muscle Cells</p>
<p><strong>Article References:</strong> TRPV4 is Associated with a Marfan Syndrome-Related Mechanosensitive Gene Program in Aortic Smooth Muscle Cells. (n.d.). <a href="https://doi.org/10.1007/s10528-026-11447-6" rel="noopener noreferrer">https://doi.org/10.1007/s10528-026-11447-6</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1007/s10528-026-11447-6" rel="noopener noreferrer">10.1007/s10528-026-11447-6</a></p>
<p><strong>Keywords:</strong> Marfan syndrome, TRPV4, mechanotransduction, vascular smooth muscle cells, aortic aneurysm, inflammation, NF-κB pathway, extracellular matrix remodeling, calcium channel, aortopathy, Biochemical Genetics, gene expression</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">203768</post-id>	</item>
		<item>
		<title>Simulating the Future: Predicting Aortic Growth in Type B Dissection Patients</title>
		<link>https://scienmag.com/simulating-the-future-predicting-aortic-growth-in-type-b-dissection-patients/</link>
		
		<dc:creator><![CDATA[Ophelia Keating]]></dc:creator>
		<pubDate>Sun, 20 Sep 2026 21:34:21 +0000</pubDate>
				<category><![CDATA[Medicine]]></category>
		<category><![CDATA[aneurysm risk assessment]]></category>
		<category><![CDATA[aortic aneurysm]]></category>
		<category><![CDATA[aortic dissection prediction]]></category>
		<category><![CDATA[aortic growth prediction]]></category>
		<category><![CDATA[aortic rupture risk prediction]]></category>
		<category><![CDATA[biomechanics]]></category>
		<category><![CDATA[biomedical engineering in cardiovascular care]]></category>
		<category><![CDATA[blood pressure management in aortic dissection]]></category>
		<category><![CDATA[computational cardiology]]></category>
		<category><![CDATA[computational modeling in cardiovascular disease]]></category>
		<category><![CDATA[CT imaging]]></category>
		<category><![CDATA[finite element modeling of aorta]]></category>
		<category><![CDATA[finite element simulation]]></category>
		<category><![CDATA[innovative approaches to aortic surgery planning]]></category>
		<category><![CDATA[inverse finite-element analysis]]></category>
		<category><![CDATA[medical imaging for aortic monitoring]]></category>
		<category><![CDATA[optimal medical therapy]]></category>
		<category><![CDATA[patient-specific modeling]]></category>
		<category><![CDATA[personalized treatment strategies for aortic dissection]]></category>
		<category><![CDATA[soft tissue biomechanics in aortic health]]></category>
		<category><![CDATA[type B aortic aneurysm growth simulation]]></category>
		<category><![CDATA[type B aortic dissection]]></category>
		<category><![CDATA[unified fiber distribution model]]></category>
		<category><![CDATA[wall stress-driven growth]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=203008</guid>

					<description><![CDATA[Researchers have developed a patient-specific finite-element framework that predicts aortic growth in type B aortic dissection with under 4 percent error using routine CT scans and blood pressure data.]]></description>
										<content:encoded><![CDATA[<p>Every year, thousands of people are diagnosed with a type B aortic dissection, a tear in the wall of the body&#8217;s largest artery that runs down through the chest and abdomen. For many of these patients, the recommended course of action is surprisingly conservative: carefully controlled blood pressure management, known as optimal medical therapy, and vigilant monitoring with repeated CT scans. Yet this strategy conceals an uncomfortable truth. Roughly 40 to 50 percent of patients managed this way will go on to develop progressive aneurysmal degeneration, in which the aorta slowly and dangerously enlarges. The clinical dilemma is that physicians cannot reliably predict which patients will remain stable and which will experience significant aortic enlargement, meaning that some patients are operated on too late while others may undergo interventions they never truly needed. A new study published in the Annals of Biomedical Engineering offers a strikingly different way forward, using the physics of soft tissue and the mathematics of finite-element simulation to forecast the future shape of each patient&#8217;s aorta.</p>
<p>The research, led by Xue Liang and Marc-Philipp H. Schmid as co-first authors, with senior authorship shared by Bradley G. Leshnower of Emory University School of Medicine and Hai Dong of Emory University and the Georgia Institute of Technology, set out to build a patient-specific computational framework capable of predicting aortic geometry and diameter growth in uncomplicated type B aortic dissection. The team included investigators from Georgia Tech, Texas Tech University, Emory University, and the Aortic Institute at Yale-New Haven Hospital, where John A. Elefteriades, one of the world&#8217;s foremost aortic surgeons, contributed his clinical expertise. What makes their approach remarkable is its reliance on data that clinicians already collect in routine practice: standard CT imaging and blood pressure measurements. No experimental tissue testing, no specialized imaging protocols, and no extra procedures were required.</p>
<p>At the heart of the framework lies a sophisticated description of aortic wall mechanics known as the unified fiber distribution, or UFD, model. The wall of the aorta is not a simple balloon-like membrane; it is a layered, fiber-reinforced composite in which networks of collagen and elastin bear load in different directions. Traditional constitutive models often assume discrete fiber families, which can struggle to capture the full diversity of fiber orientations found in real arterial tissue. The UFD model, developed previously by Dong and colleagues, treats fibers as distributed continuously across orientations within the plane of the vessel wall, providing a unified mathematical description that bridges different regimes of fiber recruitment under load. This planar distributed-fiber formulation also accounts for a so-called second kind of Poisson effect, a distinctive feature of thin, fiber-reinforced membranes. Implemented as a user-defined material subroutine in the commercial finite-element software Abaqus, the model allowed the researchers to represent the mechanical behavior of each patient&#8217;s dissected aortic wall with a high degree of physiological realism.</p>
<p>The second key innovation was geometric. In a dissection, the aortic wall splits into two channels, a true lumen and a false lumen, separated by an intimal flap, creating an enormously complex three-dimensional architecture. To track how this living structure grows over time, the researchers needed a way to map material points of the aortic tissue consistently across serial scans. They developed a novel centerline-based algorithm that determines the local material coordinates of aortic tissues by anchoring them to the curved central axis of the vessel. This algorithm, written in MATLAB, assigns each element of the finite-element mesh a local coordinate frame that follows the tortuous, patient-specific anatomy, enabling the model to distinguish local circumferential and longitudinal directions and to apply growth laws in the correct anatomical orientation.</p>
<p>The workflow the team devised is elegantly symmetrical, combining inverse and forward analyses. For each of seven type B aortic dissection patients, the researchers obtained three serial CT scans captured at different time points, along with blood pressure data. Using the geometries from the first two scans, they performed an inverse finite-element analysis: rather than predicting forward from known parameters, they worked backward from the observed second geometry to calibrate the patient-specific growth parameters that must have driven the enlargement seen between the first and second scans. Because the wall stress-driven growth framework posits that the aorta remodels in response to the mechanical stresses it experiences, this inverse step effectively reads out each patient&#8217;s individual biological propensity for enlargement, encoded in personalized growth coefficients. Once calibrated, these parameters were fed into a forward growth simulation to predict the aortic geometry at the third time point, a moment never shown to the model during calibration.</p>
<p>The results were striking. When the predicted geometries were compared against the actual CT measurements at the third time point, the model&#8217;s forecasts proved remarkably accurate. Across all seven patients, the absolute percent error in the predicted maximum aortic diameter was less than 3.5 percent, and the error in the predicted mean diameter across all anatomical locations was under 4 percent. Given that clinically meaningful aortic growth is often measured in single millimeters, this level of accuracy suggests the framework captured genuine biomechanical information rather than simply averaging away individual variation. The proof-of-concept validation demonstrates that aortic enlargement in dissection is not an inscrutable biological lottery but, at least in part, a mechanically governed process that can be quantified from clinical data.</p>
<p>The significance of this work becomes clearer when viewed against the stubborn uncertainties of current clinical practice. Decades of outcome studies have shown that risk factors for failure of medical management in type B dissection include anatomic features, false lumen patency, and aortic dimensions, yet diameter alone remains an imperfect predictor, and growth rates vary enormously between patients. Previous computational efforts have used computational fluid dynamics and fluid-structure interaction analysis to probe hemodynamic predictors such as false lumen pressure and wall shear stress, often requiring specialized 4D flow MRI data. The new framework complements this body of work by shifting attention to the solid mechanics of the wall itself and by demanding nothing more than the imaging and pressure data that every dissection patient already generates during surveillance.</p>
<p>If validated at larger scale, the implications for patient care could be substantial. A calibrated digital twin of a patient&#8217;s aorta could, in principle, support individualized surveillance intervals, identifying early on which patients are destined for rapid enlargement and warranting closer monitoring or earlier thoracic endovascular repair, while sparing stable patients unnecessary anxiety and intervention. It could also help surgeons time intervention for maximal benefit, converting an evidence-based but reactive strategy into a proactive, predictive one. The researchers are careful to frame this as a proof of concept: seven patients is a modest cohort, and the growth parameters are calibrated from observed enlargement rather than true out-of-sample prediction over entirely unseen futures. Larger, multi-center validation studies will be needed before such simulations can inform clinical guidelines, which are currently codified in the 2022 ACC/AHA aortic disease guideline.</p>
<p>Nevertheless, the study represents a compelling convergence of biomechanics, imaging, and cardiothoracic surgery. By extending a stress-driven growth framework, embedding the unified fiber distribution model into patient-specific finite-element simulations, and inventing a centerline-based method to track tissue coordinates through serial scans, the Emory-Georgia Tech-Yale team has shown that the future geometry of a dissected aorta can be computed with clinically useful precision. The MATLAB code for the coordinate-assignment algorithm and the Abaqus implementation of the UFD model are available from the corresponding authors upon reasonable request, and the study was supported by the National Heart, Lung, and Blood Institute through grant R01HL155537 and by the Carlyle Fraser Heart Center. For the hundreds of thousands of patients worldwide living under the watchful uncertainty of a dissected aorta, the prospect of a simulation that reveals tomorrow&#8217;s anatomy from today&#8217;s scan is a vision of predictive medicine that has moved measurably closer to reality.</p>
<p><strong>Subject of Research:</strong> Patient-specific finite-element prediction of aortic growth in type B aortic dissection using the unified fiber distribution model</p>
<p><strong>Article Title:</strong> Patient-Specific Aortic Growth Prediction in Type B Aortic Dissection Using Finite-Element Simulation Based on the Unified Fiber Distribution (UFD) Model</p>
<p><strong>Article References:</strong> Liang, X., Schmid, M.-P. H., Liu, M., Cebull, H. L., Zhang, M., Xu, S., Naeem, M., Oshinski, J. N., Elefteriades, J. A., Gleason, R. L., Jr., Leshnower, B. G., &amp; Dong, H. (2026). Patient-Specific Aortic Growth Prediction in Type B Aortic Dissection Using Finite-Element Simulation Based on the Unified Fiber Distribution (UFD) Model. <em>Annals of Biomedical Engineering</em>. <a href="https://doi.org/10.1007/s10439-026-04379-0" rel="noopener noreferrer">https://doi.org/10.1007/s10439-026-04379-0</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1007/s10439-026-04379-0" rel="noopener noreferrer">10.1007/s10439-026-04379-0</a></p>
<p><strong>Keywords:</strong> type B aortic dissection, aortic growth prediction, finite-element simulation, unified fiber distribution model, wall stress-driven growth, inverse finite-element analysis, patient-specific modeling, aortic aneurysm, optimal medical therapy, CT imaging, biomechanics, computational cardiology</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">203008</post-id>	</item>
	</channel>
</rss>
